Michael Richman Insider Profile
4 Followers
Michael Richman, Director at Acer Therapeutics, holds 6.52K shares in Acer Therapeutics (Ticker: ACER), holds ― shares in NextCure (Ticker: NXTC), holds 0.00 shares in GenVec Inc (Ticker: GNVC).
Michael Richman Acer Therapeutics (ACER)Director
Acer Therapeutics (ACER)
Director
Not Ranked
Michael Richman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Michael Richman does not currently own shares as a corporate insider.
A breakdown of Michael Richman's holdings
Insider Roles
Roles that Michael Richman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Michael Richman
Michael Richman's Trading History
Acer Therapeutics
Oct 04, 2016
―
Uninformative Buy
―
$4.30K
NextCure
―
President & CEO, Director
―
―
GenVec Inc
―
―
―
$0.00
Palvella Therapeutics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Michael Richman's performance on stock
You May Also Like
Michael Richman insider profile FAQ
What is the percentage of profitable transactions made by Michael Richman?
The percentage of profitable transactions made by Michael Richman is ―.
What is the average return per transaction made by Michael Richman?
The average return per transaction made by Michael Richman is ―.
What stocks does Michael Richman hold?
Michael Richman holds: ACER, NXTC, GNVC, PVLA stocks.
What was Michael Richman’s latest transaction?
Michael Richman latest transaction was an Uninformative Buy of ―.
What was Michael Richman's most profitable transaction?
Michael Richman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Michael Richman's role in Acer Therapeutics?
Michael Richman's role in Acer Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.